Needham Reiterates Buy on I-MAB, Maintains $24 Price Target
Portfolio Pulse from richadhand@benzinga.com
Needham analyst Gil Blum reiterated a Buy rating on I-MAB (NASDAQ: IMAB) and maintained a $24 price target.
June 05, 2023 | 9:17 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Needham analyst Gil Blum reiterated a Buy rating on I-MAB (NASDAQ: IMAB) and maintained a $24 price target.
The reiteration of the Buy rating and maintenance of the $24 price target by Needham analyst Gil Blum indicates a positive outlook for I-MAB. This news is likely to have a positive impact on the stock price in the short term as it reaffirms the analyst's confidence in the company's potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100